Interesstiing Clinical Trial for C-kit melanoma

› Forums › General Melanoma Community › Interesstiing Clinical Trial for C-kit melanoma

  • This topic is empty.
  • Post
    • July 1, 2013 at 2:39 am
    JerryfromFauq
    Participant

      http://clinicaltrials.gov/ct2/show/NCT01738139

      The goal of this clinical research study is to find the highest tolerable dose of the combination of ipilimumab and imatinib that can be given to patients with advanced cancer. The safety of this drug combination will also be studied.

      Ipilimumab is designed to increase the immune system's ability to fight cancer.

      http://clinicaltrials.gov/ct2/show/NCT01738139

      The goal of this clinical research study is to find the highest tolerable dose of the combination of ipilimumab and imatinib that can be given to patients with advanced cancer. The safety of this drug combination will also be studied.

      Ipilimumab is designed to increase the immune system's ability to fight cancer.

      Imatinib is designed to bind to certain proteins on the tumor cells, which may prevent the cells from growing.

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics